Beyond Air Prices $10.5 Million Underwritten Offering of Common Stock and Concurrent Private Placement
(WorldNews Health)

Beyond Air Prices $10.5 Million Underwritten Offering of Common Stock and Concurrent Private Placement December 10, 2019 9:12am EST GARDEN CITY, N.Y. and REHOVOT, Israel, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including serious lung infections and pulmonary hypertension, today announced the pricing of an underwritten public offering of 2,325,000 shares of its common stock at a price to the public of $3.66 per share. The Company has also granted the underwriters an option for a period of 30 days to...